145035-96-7
145035-96-7
Chemical Structure
DSPE-PEG3400
- CAS No.: 145035-96-7
- Formula:(C2H4O)nC43H86NO9P
- Molecular Weight:3400 (Average)
SMILES: O=C(CCCCCCCCCCCCCCCCC)OCC(COP(O)(OCCNCCOCCO)=O)OC(CCCCCCCCCCCCCCCCC)=O.[n]
Biological Activity: DSPE-PEG3400 is a phospholipid-PEG polymer conjugate that can be used in drug delivery applications. DSPE-PEG3400 serves as a material for preparing nanocarriers, which is used to prolong blood circulation time, enhance stability and improve encapsulation efficiency[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
DSPE-PEG3400 | DSPE-PEG3400 is a phospholipid-PEG polymer conjugate that can be used in drug delivery applications. DSPE-PEG3400 serves as a material for preparing nanocarriers, which is used to prolong blood circulation time, enhance stability and improve encapsulation efficiency. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Li T, et al. Photodynamic Biomimetic Liposomes Targeted to the Endoplasmic Reticulum Enhance Combined Immunotherapy for Triple-Negative Breast Cancer. ACS Appl Mater Interfaces. 2025;17(17):25112-25127. [Content Brief]
- [2]. Li L, et al. Tumor-microenvironment responsive nano-carrier system for therapy of prostate cancer. J Mater Sci Mater Med. 2023;34(10):46. Published 2023 Sep 21. [Content Brief]
